Outsourcing Formulation Development for High-Potency CompoundsByRobert HarrisMarch 1st 2016The author lists five key areas to consider when selecting a CDMO to develop highly potent formulations.
Demonstrating Therapeutic Equivalence for Generic Topical ProductsByRobert HarrisNovember 2nd 2015The determination of topical bioequivalence requires a multi-faceted approach, tailored specifically to the generic-drug formulation.